174 related articles for article (PubMed ID: 18057558)
1. Serotonin transporter gene polymorphism and BPSD in mild Alzheimer's disease.
Ueki A; Ueno H; Sato N; Shinjo H; Morita Y
J Alzheimers Dis; 2007 Nov; 12(3):245-53. PubMed ID: 18057558
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia (BPSD) in mild dementia of Alzheimer's type.
Sato N; Ueki A; Ueno H; Shinjo H; Morita Y
J Alzheimers Dis; 2009; 17(2):441-8. PubMed ID: 19363270
[TBL] [Abstract][Full Text] [Related]
3. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms.
Borroni B; Grassi M; Agosti C; Costanzi C; Archetti S; Franzoni S; Caltagirone C; Di Luca M; Caimi L; Padovani A
Neurobiol Aging; 2006 Nov; 27(11):1595-603. PubMed ID: 16257094
[TBL] [Abstract][Full Text] [Related]
4. Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association.
Quaranta D; Bizzarro A; Marra C; Vita MG; Seripa D; Pilotto A; Sebastiani V; Mecocci P; Masullo C
J Alzheimers Dis; 2009; 16(1):173-80. PubMed ID: 19158433
[TBL] [Abstract][Full Text] [Related]
5. Role of serotonin transporter polymorphisms in the behavioural and psychological symptoms in probable Alzheimer disease patients.
Pritchard AL; Pritchard CW; Bentham P; Lendon CL
Dement Geriatr Cogn Disord; 2007; 24(3):201-6. PubMed ID: 17690552
[TBL] [Abstract][Full Text] [Related]
6. Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease.
Borroni B; Grassi M; Agosti C; Archetti S; Costanzi C; Cornali C; Caltagirone C; Caimi L; Di Luca M; Padovani A
Am J Geriatr Psychiatry; 2006 Apr; 14(4):343-51. PubMed ID: 16582043
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E polymorphism and behavioral and psychological symptoms of dementia in patients with Alzheimer disease.
Chen CS; Ouyang P; Yeh YC; Lai CL; Liu CK; Yen CF; Ko CH; Yen JY; Liu GC; Juo SH
Alzheimer Dis Assoc Disord; 2012; 26(2):135-9. PubMed ID: 21617520
[TBL] [Abstract][Full Text] [Related]
8. Association study for a functional serotonin transporter gene polymorphism and late-onset Alzheimer's disease for Chinese patients.
Tsai SJ; Hong CJ; Liu TY; Cheng CY; Liu HC
Neuropsychobiology; 2001; 44(1):27-30. PubMed ID: 11408789
[TBL] [Abstract][Full Text] [Related]
9. Evaluating associations between 5-HTTLPR polymorphism and Alzheimer's disease for Korean patients.
Ha TM; Cho DM; Park SW; Joo MJ; Lee BJ; Kong BG; Kim JM; Yoon JS; Kim YH
Dement Geriatr Cogn Disord; 2005; 20(1):31-4. PubMed ID: 15832033
[TBL] [Abstract][Full Text] [Related]
10. Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy.
Manna I; Labate A; Gambardella A; Forabosco P; La Russa A; Le Piane E; Aguglia U; Quattrone A
Neurosci Lett; 2007 Jun; 421(1):52-6. PubMed ID: 17548158
[TBL] [Abstract][Full Text] [Related]
11. The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances.
Albani D; Prato F; Tettamanti M; Lovati C; Galimberti D; Restelli I; Mariani C; Quadri PL; Scarpini E; Lucca U; Forloni G
J Alzheimers Dis; 2009; 18(1):125-30. PubMed ID: 19625753
[TBL] [Abstract][Full Text] [Related]
12. Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics; 2006 Mar; 7(2):159-66. PubMed ID: 16515395
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase a polymorphism in Brazilian patients: risk factor for late-onset Alzheimer's disease?
Nishimura AL; Guindalini C; Oliveira JR; Nitrini R; Bahia VS; de Brito-Marques PR; Otto PA; Zatz M
J Mol Neurosci; 2005; 27(2):213-7. PubMed ID: 16186632
[TBL] [Abstract][Full Text] [Related]
14. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease.
Assal F; Alarcón M; Solomon EC; Masterman D; Geschwind DH; Cummings JL
Arch Neurol; 2004 Aug; 61(8):1249-53. PubMed ID: 15313842
[TBL] [Abstract][Full Text] [Related]
15. Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.
Kishida I; Aklillu E; Kawanishi C; Bertilsson L; Agren H
Neuropsychopharmacology; 2007 Oct; 32(10):2143-51. PubMed ID: 17299512
[TBL] [Abstract][Full Text] [Related]
16. No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease.
Micheli D; Bonvicini C; Rocchi A; Ceravolo R; Mancuso M; Tognoni G; Gennarelli M; Siciliano G; Murri L
J Alzheimers Dis; 2006 Dec; 10(4):371-8. PubMed ID: 17183148
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
Tsolaki AC; Gatzima O; Daniilidou M; Lazarou E; Bamidis PD; Verykouki E; Iakovidou-Kritsi Z; Tsolaki M
Neurodegener Dis; 2018; 18(4):216-224. PubMed ID: 30205398
[TBL] [Abstract][Full Text] [Related]
18. The influence of serotonin transporter polymorphisms on cortical activity: a resting EEG study.
Lee TW; Yu YW; Hong CJ; Tsai SJ; Wu HC; Chen TJ
BMC Neurosci; 2011 Apr; 12():33. PubMed ID: 21507249
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: no evidence for an association.
Kunugi H; Ueki A; Otsuka M; Isse K; Hirasawa H; Kato N; Nabika T; Kobayashi S; Nanko S
Am J Med Genet; 2000 Jun; 96(3):307-9. PubMed ID: 10898905
[TBL] [Abstract][Full Text] [Related]
20. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
